Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 07-Mar-24 4:27 PM View:  | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Teva Pharmaceutical Industr... (TEVA) | 06-Mar-24 | Planned Option Sale | 73,707 | $13.52 | $996,180.00 | (26%) 281.24K to 207.53K | |
| 07-Mar-24 4:27 PM View: | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Teva Pharmaceutical Industr... (TEVA) | 06-Mar-24 | Sale (Planned) | 3,843 | $13.52 | $51,939.70 | (2%) 207.53K to 203.69K | |
| 07-Mar-24 4:12 PM View: | Sabag Mark EVP, International Markets | Teva Pharmaceutical Industr... (TEVA) | 05-Mar-24 | Sale | 18,103 | $13.52 | $244,769.00 | (5%) 400.69K to 382.59K | |
| 07-Mar-24 4:27 PM View: | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Teva Pharmaceutical Industr... (TEVA) | 05-Mar-24 | Option Exercise | 73,707 | -- | -- | 36% 207.53K to 281.24K | |
| 07-Mar-24 4:16 PM View: | Conway Vikki L See "Remarks" | Teva Pharmaceutical Industr... (TEVA) | 05-Mar-24 | Option Exercise | 4,954 | -- | -- | 42% 11.69K to 16.65K | |
| 07-Mar-24 4:16 PM View: | Conway Vikki L See "Remarks" | Teva Pharmaceutical Industr... (TEVA) | 05-Mar-24 | Planned Option Sale | 1,427 | $13.52 | $19,286.50 | (9%) 16.65K to 15.22K | |
| 07-Mar-24 4:24 PM View: | Drape Eric Executive VP Global Operations | Teva Pharmaceutical Industr... (TEVA) | 05-Mar-24 | Option Exercise | 77,802 | -- | -- | 114% 68.11K to 145.91K | |
| 07-Mar-24 4:12 PM View: | Sabag Mark EVP, International Markets | Teva Pharmaceutical Industr... (TEVA) | 05-Mar-24 | Option Exercise | 81,897 | -- | -- | 20% 400.69K to 482.59K | |
| 07-Mar-24 4:20 PM View: | Daniell Richard Exec. VP, European Commercial | Teva Pharmaceutical Industr... (TEVA) | 05-Mar-24 | Option Exercise | 77,802 | -- | -- | 112% 69.77K to 147.57K | |
| 07-Mar-24 4:20 PM View: | Daniell Richard Exec. VP, European Commercial | Teva Pharmaceutical Industr... (TEVA) | 05-Mar-24 | Planned Option Sale | 48,629 | $13.52 | $657,240.00 | (33%) 147.57K to 98.94K | |
| 07-Mar-24 4:08 PM View: | Weiss Amir Chief Accounting Officer | Teva Pharmaceutical Industr... (TEVA) | 05-Mar-24 | Option Exercise | 3,564 | -- | -- | 12% 29.75K to 33.31K | |
| 07-Mar-24 4:12 PM View: | Sabag Mark EVP, International Markets | Teva Pharmaceutical Industr... (TEVA) | 05-Mar-24 | Option Sale | 81,897 | $13.52 | $1,107,320.00 | (17%) 482.59K to 400.69K | |
| 05-Mar-24 4:12 PM View: | Sabag Mark EVP, International Markets | Teva Pharmaceutical Industr... (TEVA) | 04-Mar-24 | Option Exercise | 33,512 | -- | -- | 9% 367.18K to 400.69K | |
| 05-Mar-24 4:21 PM View: | Daniell Richard Exec. VP, European Commercial | Teva Pharmaceutical Industr... (TEVA) | 04-Mar-24 | Option Exercise | 33,512 | -- | -- | 25% 132.02K to 165.53K | |
| 05-Mar-24 4:21 PM View: | Daniell Richard Exec. VP, European Commercial | Teva Pharmaceutical Industr... (TEVA) | 04-Mar-24 | Planned Option Sale | 95,762 | $13.34 | $1,277,210.00 | (58%) 165.53K to 69.77K | |
| 05-Mar-24 4:03 PM View: | Weiss Amir Chief Accounting Officer | Teva Pharmaceutical Industr... (TEVA) | 04-Mar-24 | Option Exercise | 10,676 | -- | -- | 56% 19.07K to 29.75K | |
| 05-Mar-24 4:16 PM View: | Hughes Eric A See "Remarks" | Teva Pharmaceutical Industr... (TEVA) | 04-Mar-24 | Planned Option Sale | 8,045 | $13.34 | $107,299.00 | (32%) 24.9K to 16.86K | |
| 05-Mar-24 4:08 PM View: | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Teva Pharmaceutical Industr... (TEVA) | 04-Mar-24 | Option Exercise | 33,512 | -- | -- | 19% 174.02K to 207.53K | |
| 05-Mar-24 4:27 PM View: | Francis Richard D President and CEO | Teva Pharmaceutical Industr... (TEVA) | 04-Mar-24 | Planned Option Sale | 31,061 | $13.34 | $414,270.00 | (20%) 154.36K to 123.3K | |
| 05-Mar-24 4:39 PM View: | Conway Vikki L See "Remarks" | Teva Pharmaceutical Industr... (TEVA) | 04-Mar-24 | Option Exercise | 7,117 | -- | -- | 88% 8.11K to 15.22K | |
| 05-Mar-24 4:39 PM View: | Conway Vikki L See "Remarks" | Teva Pharmaceutical Industr... (TEVA) | 04-Mar-24 | Planned Option Sale | 3,532 | $13.37 | $47,234.50 | (23%) 15.22K to 11.69K | |
| 05-Mar-24 4:25 PM View: | Drape Eric Executive VP Global Operations | Teva Pharmaceutical Industr... (TEVA) | 04-Mar-24 | Option Exercise | 33,512 | -- | -- | 75% 44.42K to 77.93K | |
| 05-Mar-24 4:03 PM View: | Weiss Amir Chief Accounting Officer | Teva Pharmaceutical Industr... (TEVA) | 03-Mar-24 | Option Exercise | 5,179 | -- | -- | 37% 13.89K to 19.07K | |
| 05-Mar-24 4:16 PM View: | Hughes Eric A See "Remarks" | Teva Pharmaceutical Industr... (TEVA) | 03-Mar-24 | Option Exercise | 24,900 | -- | -- | 100% 0 to 24.9K | |
| 05-Mar-24 4:27 PM View: | Francis Richard D President and CEO | Teva Pharmaceutical Industr... (TEVA) | 03-Mar-24 | Option Exercise | 67,231 | -- | -- | 77% 87.13K to 154.36K | |
| 05-Mar-24 4:08 PM View: | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Teva Pharmaceutical Industr... (TEVA) | 03-Mar-24 | Option Exercise | 49,800 | -- | -- | 40% 124.22K to 174.02K | |
| 05-Mar-24 4:39 PM View: | Conway Vikki L See "Remarks" | Teva Pharmaceutical Industr... (TEVA) | 03-Mar-24 | Option Exercise | 5,179 | -- | -- | 177% 2.93K to 8.11K | |
| 05-Mar-24 4:25 PM View: | Drape Eric Executive VP Global Operations | Teva Pharmaceutical Industr... (TEVA) | 03-Mar-24 | Option Exercise | 24,900 | -- | -- | 128% 19.52K to 44.42K | |
| 05-Mar-24 4:12 PM View: | Sabag Mark EVP, International Markets | Teva Pharmaceutical Industr... (TEVA) | 03-Mar-24 | Option Exercise | 24,900 | -- | -- | 7% 342.28K to 367.18K | |
| 05-Mar-24 4:21 PM View: | Daniell Richard Exec. VP, European Commercial | Teva Pharmaceutical Industr... (TEVA) | 03-Mar-24 | Option Exercise | 62,250 | -- | -- | 89% 69.77K to 132.02K | |
| 01-Mar-24 6:45 AM View: | Drape Eric Executive VP Global Operations | Teva Pharmaceutical Industr... (TEVA) | 28-Feb-24 | Planned Option Sale | 9,815 | $13.12 | $128,734.00 | (50%) 19.52K to 9.7K | |
| 01-Mar-24 6:54 AM View: | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Teva Pharmaceutical Industr... (TEVA) | 28-Feb-24 | Option Exercise | 18,430 | -- | -- | 17% 105.79K to 124.22K | |
| 01-Mar-24 6:40 AM View: | Conway Vikki L See "Remarks" | Teva Pharmaceutical Industr... (TEVA) | 28-Feb-24 | Option Exercise | 4,294 | -- | -- | 100% 0 to 4.29K | |
| 01-Mar-24 6:45 AM View: | Drape Eric Executive VP Global Operations | Teva Pharmaceutical Industr... (TEVA) | 28-Feb-24 | Option Exercise | 19,515 | -- | -- | 1951500% 1 to 19.52K | |
| 01-Mar-24 6:52 AM View: | Sabag Mark EVP, International Markets | Teva Pharmaceutical Industr... (TEVA) | 28-Feb-24 | Option Exercise | 20,599 | -- | -- | 6% 321.68K to 342.28K | |
| 01-Mar-24 6:43 AM View: | Daniell Richard Exec. VP, European Commercial | Teva Pharmaceutical Industr... (TEVA) | 28-Feb-24 | Option Exercise | 20,599 | -- | -- | 30% 69.77K to 90.37K | |
| 01-Mar-24 6:40 AM View: | Conway Vikki L See "Remarks" | Teva Pharmaceutical Industr... (TEVA) | 28-Feb-24 | Planned Option Sale | 1,366 | $13.12 | $17,916.50 | (32%) 4.29K to 2.93K | |
| 01-Mar-24 6:57 AM View: | Bergwerk Dov Acting Chief Legal Officer | Teva Pharmaceutical Industr... (TEVA) | 28-Feb-24 | Option Exercise | 6,653 | -- | -- | 7% 90.33K to 96.98K | |
| 01-Mar-24 6:48 AM View: | Weiss Amir Chief Accounting Officer | Teva Pharmaceutical Industr... (TEVA) | 28-Feb-24 | Option Exercise | 3,219 | -- | -- | 30% 10.68K to 13.89K | |
| 01-Mar-24 6:43 AM View: | Daniell Richard Exec. VP, European Commercial | Teva Pharmaceutical Industr... (TEVA) | 28-Feb-24 | Planned Option Sale | 20,599 | $13.12 | $270,176.00 | (23%) 90.37K to 69.77K | |
| 21-Feb-24 7:37 AM View: | Drape Eric Executive VP Global Operations | Teva Pharmaceutical Industr... (TEVA) | 16-Feb-24 | Private Sale | 173,261 | $13.05 | $2,261,900.00 | (100%) 173.26K to 1 | |
| 20-Feb-24 7:42 AM View: | Francis Richard D President and CEO | Teva Pharmaceutical Industr... (TEVA) | 15-Feb-24 | Planned Option Sale | 74,530 | $13.15 | $980,174.00 | (46%) 161.66K to 87.13K | |
| 20-Feb-24 7:42 AM View: | Francis Richard D President and CEO | Teva Pharmaceutical Industr... (TEVA) | 15-Feb-24 | Option Exercise | 161,655 | -- | -- | 100% 0 to 161.66K | |
| 15-Feb-24 7:37 AM View: | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Teva Pharmaceutical Industr... (TEVA) | 13-Feb-24 | Option Exercise | 6,630 | -- | -- | 7% 99.16K to 105.79K | |
| 05-Feb-24 7:49 AM View: | Weiss Amir Chief Accounting Officer | Teva Pharmaceutical Industr... (TEVA) | 01-Feb-24 | Private Sale | 31,766 | $12.37 | $392,955.00 | (75%) 42.44K to 10.68K | |
| 09-Aug-23 4:02 PM View: | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Teva Pharmaceutical Industr... (TEVA) | 07-Aug-23 | Private Sale | 35,125 | $9.73 | $341,889.00 | (26%) 134.29K to 99.16K | |
| 07-Aug-23 4:15 PM View: | Weiss Amir Chief Accounting Officer | Teva Pharmaceutical Industr... (TEVA) | 04-Aug-23 | Private Sale | 1,981 | $9.92 | $19,657.60 | (4%) 44.42K to 42.44K | |
| 07-Aug-23 4:04 PM View: | Elstein Amir Director | Teva Pharmaceutical Industr... (TEVA) | 04-Aug-23 | Option Exercise | 15,810 | -- | -- | < 1% 2.06M to 2.07M | |
| 07-Aug-23 4:06 PM View: | Mignone Roberto Director | Teva Pharmaceutical Industr... (TEVA) | 04-Aug-23 | Option Exercise | 15,810 | -- | -- | < 1% 3.06M to 3.07M | |
| 07-Aug-23 4:08 PM View: | Nisen Perry Director | Teva Pharmaceutical Industr... (TEVA) | 04-Aug-23 | Option Exercise | 15,810 | -- | -- | 27% 58.77K to 74.58K |
